ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Metagenomi Inc

Metagenomi Inc (MGX)

4.10
0.05
( 1.23% )
Updated: 05:21:39

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.10
Bid
4.08
Offer
4.10
Volume
904,226
3.825 Day's Range 4.40
1.61 52 Week Range 12.74
Market Cap
Previous Close
4.05
Open
4.11
Last Trade Time
05:21:58
Financial Volume
US$ 3,724,814
VWAP
4.1193
Average Volume (3m)
1,843,654
Shares Outstanding
37,423,917
Dividend Yield
-
PE Ratio
-2.26
Earnings Per Share (EPS)
-1.82
Revenue
44.76M
Net Profit
-68.26M

About Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was US$4.05. Over the last year, Metagenomi shares have traded in a share price range of US$ 1.61 to US$ 12.74.

Metagenomi currently has 37,423,917 shares in issue. The market capitalisation of Metagenomi is US$151.57 million. Metagenomi has a price to earnings ratio (PE ratio) of -2.26.

MGX Latest News

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference โ€œRNA at the Bench and Bedside IVโ€

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up MGX-001 bioengineered FVIII...

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 14, 2024 NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Gross...

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track...

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.824.24242424243.34.42.910122642613.66004254CS
42.17112.4352331611.934.921.8350052203.98775094CS
121.8783.85650224222.234.921.6118436543.70225475CS
260.5515.49295774653.555.49991.619435443.64342536CS
52-6.15-6010.2512.741.616114774.2575493CS
156-6.15-6010.2512.741.616114774.2575493CS
260-6.15-6010.2512.741.616114774.2575493CS

MGX - Frequently Asked Questions (FAQ)

What is the current Metagenomi share price?
The current share price of Metagenomi is US$ 4.10
How many Metagenomi shares are in issue?
Metagenomi has 37,423,917 shares in issue
What is the market cap of Metagenomi?
The market capitalisation of Metagenomi is USD 151.57M
What is the 1 year trading range for Metagenomi share price?
Metagenomi has traded in the range of US$ 1.61 to US$ 12.74 during the past year
What is the PE ratio of Metagenomi?
The price to earnings ratio of Metagenomi is -2.26
What is the cash to sales ratio of Metagenomi?
The cash to sales ratio of Metagenomi is 3.45
What is the reporting currency for Metagenomi?
Metagenomi reports financial results in USD
What is the latest annual turnover for Metagenomi?
The latest annual turnover of Metagenomi is USD 44.76M
What is the latest annual profit for Metagenomi?
The latest annual profit of Metagenomi is USD -68.26M
What is the registered address of Metagenomi?
The registered address for Metagenomi is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Metagenomi website address?
The website address for Metagenomi is www.metagenomi.co
Which industry sector does Metagenomi operate in?
Metagenomi operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRCTDirect Digital Holdings Inc
US$ 3.34
(507.27%)
39.74M
RELIReliance Global Group Inc
US$ 3.62
(201.67%)
96.81M
TRAWTraws Pharma Inc
US$ 13.39
(166.73%)
25.85M
RAPTRAPT Therapeutics Inc
US$ 1.74
(110.81%)
122.86M
OCCOptical Cable Corporation
US$ 4.1293
(96.63%)
32.24M
AILEiLearningEngines Inc
US$ 0.2254
(-74.53%)
15.28M
MGOLMGO Global Inc
US$ 0.455
(-52.11%)
10.47M
YHCLQR House Inc
US$ 1.085
(-38.00%)
1.06M
ADGMAdagio Medical Holdings Inc
US$ 1.06
(-35.76%)
4.33M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.418599
(-31.56%)
135.96M
EDBLEdible Garden AG Inc
US$ 0.3901
(64.11%)
373.54M
RGTIRigetti Computing Inc
US$ 11.1399
(18.89%)
188.82M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.418599
(-31.56%)
135.96M
RAPTRAPT Therapeutics Inc
US$ 1.7456
(111.49%)
122.87M
RIMEAlgorhythm Holdings Inc
US$ 0.0972
(27.23%)
110.56M

MGX Discussion

View Posts
Landwehr Landwehr 2 days ago
There hasn't been any news in a while. However, the chart is looking really good
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 days ago
MGX under $5

[color=red][/color]
👍 1
Landwehr Landwehr 3 days ago
MGX still looking good. A mild new release will send this to 4.5. 
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 5 days ago
GAVE IT A CHANCE...SOLD IT
๐Ÿ‘๏ธ0
Landwehr Landwehr 5 days ago
We need a news release for this to go back up. I'm long on this stock 
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 5 days ago
MGX GAPPING BACK UP...LAST ATTEMPT
๐Ÿ‘๏ธ0
Landwehr Landwehr 6 days ago
If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle. 
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 6 days ago
5 DAY DOWN TREND SEEMS TO HAVE STOPPED
๐Ÿ‘๏ธ0
Landwehr Landwehr 6 days ago
Very good consolidation while no new news
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 6 days ago
MGX BUILDING A FOUNDATION
👍 1
Landwehr Landwehr 1 week ago
The next news release will ignite this stock. 
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 1 week ago
No, they are well funded well into 2025 and even beyond late 2025.
๐Ÿ‘๏ธ0
Millenium323 Millenium323 1 week ago
Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth
👍 1
Landwehr Landwehr 1 week ago
This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation 
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
I sold at $4.50.
๐Ÿ‘๏ธ0
frans frans 2 weeks ago
MGX need money ???
๐Ÿ‘๏ธ0
frans frans 2 weeks ago
MGX company work for MM not for shaholders and selling shares into market
๐Ÿ‘๏ธ0
frans frans 2 weeks ago
all schort what I see on my L2 MM's 10 - 12 sametime
๐Ÿ‘๏ธ0
theorysuit theorysuit 2 weeks ago
This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.
๐Ÿ‘๏ธ0
Landwehr Landwehr 2 weeks ago
I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed 
๐Ÿ‘๏ธ0
frans frans 2 weeks ago
I am not out I am long
๐Ÿ‘๏ธ0
theorysuit theorysuit 2 weeks ago
Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.
๐Ÿ‘๏ธ0
Landwehr Landwehr 2 weeks ago
A ride to $10
๐Ÿ‘๏ธ0
frans frans 2 weeks ago
what is going on here ??
๐Ÿ‘๏ธ0
TrendTrade2016 TrendTrade2016 2 weeks ago
MGX MONSTER
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
This is why it ran today with no news, someone knew it was coming

https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
Corporate presentation just an hour ago.

https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much theyโ€™ll charge for a cureโ€ฆ.. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
https://metagenomi.co/discovery-platform
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.
👍 1
Monksdream Monksdream 2 weeks ago
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editยญing toolbox, therยญaยญpeuยญtic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 weeks ago
UP OFF THE MAT, maybe it will grow legs
๐Ÿ‘๏ธ0
Landwehr Landwehr 2 weeks ago
This could get to $5 this week
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 weeks ago
MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783
👍 1
eur06 eur06 2 weeks ago
Just got on lineโ€ฆ.it looks pretty good!!
Trying to get some.
๐Ÿ‘๏ธ0
theorysuit theorysuit 2 weeks ago
LfG!
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.
👍 1
TrendTrade2016 TrendTrade2016 2 weeks ago
mgx blowing up
๐Ÿ‘๏ธ0
dinogreeves dinogreeves 2 weeks ago
1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.
👍 1
KIPK KIPK 3 months ago
POS ....You are
๐Ÿ‘๏ธ0
KIPK KIPK 3 months ago
You are a POS dude....
๐Ÿ‘๏ธ0
theorysuit theorysuit 4 months ago
Added again here in full size. Data looks fantastic.
๐Ÿ‘๏ธ0
theorysuit theorysuit 4 months ago
https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.
๐Ÿ‘๏ธ0
theorysuit theorysuit 4 months ago
buying in small chunks under $3.
๐Ÿ‘๏ธ0
theorysuit theorysuit 4 months ago
i'm buying it up as speculative play on cash value. Will hold a tight stop loss.
๐Ÿ‘๏ธ0
theorysuit theorysuit 5 months ago
every stock that i look into, you are here :)
๐Ÿ‘๏ธ0
jondoeuk jondoeuk 8 months ago
The IPO was way too early, and one of the few pillars of its business plan was the partnership. The fact that Moderna walked away means that has collapsed. In the future, IP could be another issue.
๐Ÿ‘๏ธ0
jondoeuk jondoeuk 8 months ago
Try not to end up being a bag holder for VC's shifting overvalued ''dream companies.''
๐Ÿ‘๏ธ0
jondoeuk jondoeuk 8 months ago
MRNA walks away from the deal that could have generated up to $3B, handing back full global rights and related technologies.
๐Ÿ‘๏ธ0